A
Abingworth Portfolio holdings
AUM
$307M
This Quarter Return
+20.2%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$104M
AUM Growth
+$104M
(+9.3%)
Cap. Flow
-$2.82M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
85.86%
Holding
22
New
2
Increased
1
Reduced
1
Closed
2
Top Buys
1 |
NOVN
Novan, Inc. Common Stock
NOVN
|
$4.03M |
2 |
Ocugen
OCGN
|
$543K |
3 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$221K |
Top Sells
1 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$7.38M |
2 |
Aurinia Pharmaceuticals
AUPH
|
$232K |
3 |
EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
|
$4K |
Sector Composition
1 | Healthcare | 85.98% |
2 | Technology | 1.92% |